US EditionIntrinsic Therapeutics Names Keith Valentine President and Chief Executive Officer
- Intrinsic Therapeutics appointed Keith Valentine as President and CEO on April 10, 2025, in Boston.
- The appointment occurred because Valentine brings over thirty years of executive experience to the company.
- Valentine previously held leadership roles at NuVasive, SeaSpine, and Orthofix, demonstrating success in commercializing spinal implants.
- Ryan Drant, Board Chairman, said, "We are thrilled to welcome Keith Valentine as Intrinsic's new Chief Executive Officer."
- Valentine's leadership aims to maximize the Barricaid opportunity, as its CPT-1 code becomes effective in January 2026.
Insights by Ground AI
Does this summary seem wrong?
32 Articles
32 Articles
All
Left
2
Center
10
Right
2
The Conway Daily Sun+31 Reposted by 31 other sources
Intrinsic Therapeutics Names Keith Valentine President and Chief Executive Officer
BOSTON, April 10, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company driving to change the standard of care for lumbar discectomy patients with large annular defects by reducing reoperations for reherniations by 81% with its Barricaid Annular Closure Device,…
Coverage Details
Total News Sources32
Leaning Left2Leaning Right2Center10Last UpdatedBias Distribution71% Center
Bias Distribution
- 71% of the sources are Center
71% Center
14%
C 71%
14%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
